When compared against non-phospho-tau blood biomarkers – NFL, Aβ ratio, t-tau and glial fibrillary acidic protein – plasma p-tau were significantly better at differentiating between AD and CU individuals [89]. This evidence concerns the gene MAPT and Alzheimer disease.